Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection
- PMID: 8375482
- DOI: 10.1006/expr.1993.1069
Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection
Abstract
Irradiated sporozoites are generally thought to elicit protective immune responses that are parasite stage and species specific. But immunization with Plasmodium falciparum sporozoites delivered by the bite of infected mosquitoes protects an average of 60% mice from Plasmodium berghei sporozoite infection. Protection appears to be specific as P. falciparum sporozoite-immunized mice protected against P. berghei remain susceptible to Plasmodium yoelii sporozoite infection. Passively transferred immunoglobulin from P. falciparum sporozoite-immunized mouse serum protected naive mice against challenge with P. berghei sporozoites, indicating that cross-protection is mediated, at least in part, by anti-sporozoite antibody. Antibody-mediated protection may not be due to cross-reaction between P. falciparum and P. berghei CS proteins because mice immunized with the recombinant P. falciparum CS protein repeat vaccine candidate, R32tet32, remain susceptible to P. berghei sporozoite infection.
Similar articles
-
Characterization of a sporozoite antigen common to Plasmodium falciparum and Plasmodium berghei.Mol Biochem Parasitol. 1995 Feb;69(2):239-46. doi: 10.1016/0166-6851(94)00198-v. Mol Biochem Parasitol. 1995. PMID: 7770087
-
A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.Infect Immun. 1995 Nov;63(11):4375-81. doi: 10.1128/iai.63.11.4375-4381.1995. Infect Immun. 1995. PMID: 7591073 Free PMC article.
-
Cross-protection between attenuated Plasmodium berghei and P. yoelii sporozoites.Parasite Immunol. 2007 Nov;29(11):559-65. doi: 10.1111/j.1365-3024.2007.00976.x. Parasite Immunol. 2007. PMID: 17944745 Free PMC article.
-
Host-parasite interactions and immunity to irradiated sporozoites.Immunol Lett. 1990 Aug;25(1-3):39-42. doi: 10.1016/0165-2478(90)90088-8. Immunol Lett. 1990. PMID: 2283161 Review.
-
Five decades of clinical assessment of whole-sporozoite malaria vaccines.Front Immunol. 2022 Sep 8;13:977472. doi: 10.3389/fimmu.2022.977472. eCollection 2022. Front Immunol. 2022. PMID: 36159849 Free PMC article. Review.
Cited by
-
Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.PLoS One. 2010 May 19;5(5):e10685. doi: 10.1371/journal.pone.0010685. PLoS One. 2010. PMID: 20502667 Free PMC article.
-
Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one?Infect Immun. 2008 Mar;76(3):873-8. doi: 10.1128/IAI.00431-07. Epub 2007 Dec 3. Infect Immun. 2008. PMID: 18056479 Free PMC article. Review. No abstract available.
-
A genetically modified Plasmodium berghei parasite as a surrogate for whole-sporozoite vaccination against P. vivax malaria.NPJ Vaccines. 2022 Dec 16;7(1):163. doi: 10.1038/s41541-022-00585-8. NPJ Vaccines. 2022. PMID: 36526627 Free PMC article.
-
Strain-specific immunity induced by immunization with pre-erythrocytic stages of Plasmodium chabaudi.Parasite Immunol. 2011 Jan;33(1):73-8. doi: 10.1111/j.1365-3024.2010.01251.x. Parasite Immunol. 2011. PMID: 21189655 Free PMC article.
-
The Case for Exploiting Cross-Species Epitopes in Malaria Vaccine Design.Front Immunol. 2020 Feb 27;11:335. doi: 10.3389/fimmu.2020.00335. eCollection 2020. Front Immunol. 2020. PMID: 32174924 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical